Highlights of the 14th World Vaccine Congress – A Cell Culture Perspective

Highlights of the 14th World Vaccine Congress – A Cell Culture Perspective The World Vaccine Congress is the World’s leading conference that covers all elements of vaccine research, development, manufacture and distribution. This report by Cell Culture Dish focuses in on the discussions that took place around cell culture, looking at key presentations such as: Quantitating Influenza Viruses- Ewan Plant (CBER, …

Presentation download: Single use products for bioproduction: available options for cell culture and downstream processing.

Challenges facing vaccine producers include: different technology platforms make it difficult to standardize facility design and equipment; unique facility and equipment may be required for an individual vaccine or class of vaccines, and finally, many vaccines are typically low volume with high throughput products. In conclusion, there is no ‘one-size fits all' facility for all vaccine products and processes! Susan …

Manufacturing of Vaccines – Cell Culture Technology Gradually Replacing Egg-Based Manufacturing

        GBI Research, the leading business intelligence provider, has released its latest research report, "Manufacturing of Vaccines – Cell Culture Technology Gradually Replacing Egg-Based Manufacturing". The report provides in-depth analysis of the drivers and restraints that affect the growth of the vaccine manufacturing process. The report discusses the egg-based and cell culture-based vaccine manufacturing processes in depth. …

Can #bio-informatic analysis deliver #vaccine #cell line qualification?

One of the biggest challenges standing in the way of cell culture vaccine production is achieving cell line qualification, and standing in the way of this is proving you have scanned for all known and unknown pathogens throughout bio-production. In April the leading players working to try to achieve this goal are going to be in Washington D.C. discussing their …